2025 Davos is coming. The company is also enamored with Global Lighthouse Network by World Economic Forum. We know what that Forum represents. USA has DeepState. WEF is DeepGlobalism.
At JPM Conf. Biomarin presentation did not convince investors and stock has tanked.
Interesting that CEO brought his new set of upper management and only Brian from the old set.
This shows that old management is on its way out as someone indicated on this site. Would such replacement help the company? New management may not understand specifics of future portfolio. Or they are there to complete M&A deal.
Layoffs!
Cell therapy in question.
Gilead is in retreat, so how about Kite?
Cell therapy is like a laboratory and clinical procedure development, not a typical pharma drug development. Often at enormous cost. And a market size and economics?
Genentech under Roche is diminishing continually. Manufacturing related jobs are practically only in Oregon. There are fewer opportunities in R&D in SSF. Wonder what is going to be shut down next. Layoffs are probable in 2025.
Genentech is Roche.
Decisions are made in Switzerland and are executed in the US. Locals have not much to say. Genentech name is a cover to take the blame.
This is a shady company. The management out of San Diego and the CEO are selling non-existent products (and so timelines are not real), other than the Cologuard. Investors please watch out.
